Press Release (ePRNews.com) - SEOUL, South Korea - Jun 01, 2016 - Hironic, a leading innovator of medical aesthetic laser and energy devices, announced today the launch of JUVINA™ Hyaluronic Acid (HA) Filler. With a strong global network and customer base, Hironic now plans to accelerate entry into the global medical aesthetic market with its new filler line-up. Hironic’s strategy is to rapidly gain the filler market share by utilizing its vast network of global distributors which already sell Hironic’s lineup of medical aesthetic devices. With Hironic’s recognition among skin and plastic surgery clinics worldwide, JUVINA is expected to contribute highly to Hironic’s long-term revenue growth.
JUVINA provides lift to the cheeks and volume to correct and smooth smile lines. JUVINA is safe to use because it is made up of Hyaluronic Acid (HA), a natural substance found in the human body. When injected into the dermis, Hyaluronic Acid enhances the skin’s elasticity and ability to retain moisture. Patients can immediately feel the difference with a more youthful-looking appearance. With Hironic’s proprietary filler technology, the results are natural and long lasting. For optimal treatment of each skin area, JUVINA collection of fillers comes in 6 different variations – 3 levels of intensity (Soft, Balance and Intense), with and without Lidocaine.
According to industry sources, the global facial aesthetics market is expected to grow at a CAGR of 11.6% until 2020. The dermal filler market is expected to grow 13% annually and reach $2.7 billion by 2020. Furthermore, the Chinese market is also expected to grow explosively at a CAGR of 30%, from $8.4 million in 2014 to $230 million by 2018.
Hironic will launch JUVINA at the end of June and will focus on overseas market development in the early stages. “We, at Hironic, are excited to finally launch JUVINA filler which we have planned for several years. We will continue to provide innovative new products and services to our valued customers around the world,” said Jinu Lee, CEO of Hironic.
Established in 2006, Hironic is a KOSDAQ-listed company which manufactures innovative medical aesthetic laser and energy devices for skin and plastic surgery clinics. Committed to creating value for human beauty and health, Hironic provides a diverse range of products which includes DOUBLO™, a skin-lifting device utilizing HIFU (High Intensity Focused Ultrasound) technology for skin rejuvenation, MICOOL™, which effectively destroys fat cells for body shaping using cryo fat reduction technology, MIRACLEAR™ for acne treatment and EASYMO GRAFT™, a non-invasive hair transplant device. Hironic brand continues to be recognized, valued and trusted by global customers because of its beautifully designed, innovative and reliable technology.
For more information about HIRONIC and its products, please visit: www.hironic.com